Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-19-029735
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-15 16:18:59
Reporting Period:
2019-05-13
Accepted Time:
2019-05-15 16:18:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1633070 Axcella Health Inc. AXLA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222012 Noubar Afeyan 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1255927 Jr M Edwin Kania 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1503559 Flagship Ventures Fund Iv, L.p. 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1508051 Flagship Ventures Fund Iv General Partner Llc 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1508052 Flagship Ventures Fund 2007, L.p. 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1508053 Flagship Ventures 2007 General Partner Llc 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1590973 Flagship Ventures Fund Iv-Rx, L.p. 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1642578 Flagship Venturelabs Iv, Llc 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1677345 Flagship Ventures Opportunities Fund I, L.p. 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
1725004 Flagship Ventures Opportunities Fund I General Partner Llc 55 Cambridge Parkway, Suite 800E
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-13 751,691 $0.00 1,430,301 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 2,255,074 $0.00 2,255,074 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 209,933 $0.00 1,640,234 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 503,840 $0.00 2,758,914 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 545,826 $0.00 545,826 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 120,795 $0.00 1,761,029 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 335,457 $0.00 3,094,371 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 82,324 $0.00 628,150 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 194,409 $0.00 3,288,780 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 48,602 $0.00 676,752 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 486,023 $0.00 486,023 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-05-13 500,000 $20.00 986,023 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2019-05-13 1,384,615 $0.00 751,691 $0.00
Common Stock Series A Preferred Stock Disposition 2019-05-13 4,153,847 $0.00 2,255,074 $0.00
Common Stock Series B Preferred Stock Disposition 2019-05-13 386,697 $0.00 209,933 $0.00
Common Stock Series B Preferred Stock Disposition 2019-05-13 928,074 $0.00 503,840 $0.00
Common Stock Series B Preferred Stock Disposition 2019-05-13 1,005,413 $0.00 545,826 $0.00
Common Stock Series C Preferred Stock Disposition 2019-05-13 222,506 $0.00 120,795 $0.00
Common Stock Series C Preferred Stock Disposition 2019-05-13 617,914 $0.00 335,457 $0.00
Common Stock Series C Preferred Stock Disposition 2019-05-13 151,643 $0.00 82,324 $0.00
Common Stock Series E Preferred Stock Disposition 2019-05-13 358,102 $0.00 194,409 $0.00
Common Stock Series E Preferred Stock Disposition 2019-05-13 89,525 $0.00 48,602 $0.00
Common Stock Series E Preferred Stock Disposition 2019-05-13 895,255 $0.00 486,023 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 678,610 Indirect See Footnote
Common Stock 2,035,830 Indirect See Footnote
Footnotes
  1. Shares held by Flagship Ventures Fund 2007, L.P. ("Flagship Fund 2007"). Flagship Ventures 2007 General Partner LLC ("Fund 2007 GP") is the general partner of Flagship Fund 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Fund 2007 GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship 2007 GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund 2007. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
  2. Shares held by Flagship VentureLabs IV, LLC ("VentureLabs IV"). Flagship Ventures Fund IV, L.P. ("Flagship Fund IV") is a member of VentureLabs IV and also serves as its manager. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by VentureLabs IV. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
  3. Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-1.842 basis upon the closing of the Issuer's initial public offering.
  4. Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  5. Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering.
  6. Shares held by Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship Fund IV GP. While Mr. Kania is retired from Flagship Pioneering, Inc., he continues to serve as a manager of Flagship Fund IV GP. Each of these individuals and entities may be deemed to share voting and investment power with respect to all shares held by Flagship Fund IV-Rx. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
  7. Each share of Series C Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering.
  8. Each share of Series E Preferred Stock converted into shares of the Issuer's Common Stock on a one-for-1.842 basis upon the closing of the Issuer's initial public offering.
  9. Shares held by Flagship Ventures Opportunities Fund I, L.P. ("Flagship Opportunities I"). Flagship Ventures Opportunities Fund I General Partner LLC ("Flagship Opportunities GP") is the general partner of Flagship Opportunities I. Noubar B. Afeyan, Ph.D. serves as sole manager of Flagship Opportunities GP and may be deemed to possess sole voting and investment power with respect to all shares held by Flagship Opportunities I. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.